VIR

Vir Biotechnology, Inc.

Halal Rating :
Comfortable
Last Price $7.43 Last updated:
Market Cap $1.13b
7D Change 1.02%
1 Year Change -27.13%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The company's primary focus is on developing treatments for viral and bacterial infections, including COVID-19, influenza, hepatitis B virus (HBV), and HIV.

The company's approach leverages four technological platforms: antibody, T cell, innate immunity, and siRNA. Their revenue primarily comes from collaboration agreements and product sales related to their therapeutic developments.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.38m $233.68m - - 0.00% 0.00%
June 30, 2024 $3.08m $142.86m - $-18846000.0 0.00% 13.19%
March 31, 2024 $56.38m $136.46m - - 0.00% 0.00%

Company Impact

Help us evaluate Vir Biotechnology, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates